BlackRock Institutional Trust’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

BlackRock Institutional Trust’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9.84M	Buy	726,524 +50,569	+7%	+$705K	﹤0.01%	2413
2016 Q3	$8.32M	Buy	675,955 +22,193	+3%	+$262K	﹤0.01%	2445
2016 Q2	$7.17M	Sell	653,762 -3,851	-0.6%	-$43.1K	﹤0.01%	2492
2016 Q1	$7.19M	Sell	657,613 -179,683	-21%	-$2.27M	﹤0.01%	2474
2015 Q4	$14.5M	Sell	837,296 -117,669	-12%	-$2.11M	﹤0.01%	2087
2015 Q3	$19M	Sell	954,965 -125,271	-12%	-$2.87M	﹤0.01%	1878
2015 Q2	$17.7M	Buy	1,080,236 +275,205	+34%	+$4.77M	﹤0.01%	2000
2015 Q1	$12.5M	Buy	805,031 +371,535	+86%	+$5.76M	﹤0.01%	2243
2014 Q4	$6.19M	Buy	433,496 +271,243	+167%	+$2.86M	﹤0.01%	2630
2014 Q3	$1.05M	Sell	162,253 -70,940	-30%	-$471K	﹤0.01%	3306
2014 Q2	$1.61M	Sell	233,193 -175,437	-43%	-$1.24M	﹤0.01%	3283
2014 Q1	$2.92M	Buy	408,630 +131,892	+48%	+$1.13M	﹤0.01%	3003
2013 Q4	$2.6M	Buy	276,738 +127,268	+85%	+$908K	﹤0.01%	3054
2013 Q3	$933K	Sell	149,470 -87,265	-37%	-$545K	﹤0.01%	3378
2013 Q2	$1.56M	Buy	+236,735	New	+$1.88M	﹤0.01%	3190

Other funds holding SCMP

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Redwood Investments Boston, Massachusetts $267M AUM 11.99% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock Institutional Trust's SCMP Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 7.5% in Q4 2016, buying an estimated $705K and bringing the position to 726,524 shares worth $9.84M. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

BlackRock Institutional Trust first reported a position in SCMP in Q2 2013 and has held it in 15 quarters since. The position peaked at $19M in Q3 2015. 165 funds tracked by Wall St. Rank hold SCMP as of Q4 2016.

BlackRock Institutional Trust held 726,524 shares of Sucampo Pharmaceuticals, Inc. worth $9.84M as of Q4 2016.
BlackRock Institutional Trust bought 50,569 Sucampo Pharmaceuticals, Inc. shares in Q4 2016, an estimated $705K.
Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2413 holding.
BlackRock Institutional Trust first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Sucampo Pharmaceuticals, Inc. position peaked at $19M in Q3 2015.
165 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.